ARCHIVES

Cyramza-Docetaxel Combination Extends OS In Second-Line NSCLC

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Committee Okays High Dose Methotrexate, Mitxantrone In ANL; reverse Breast Cancer Vote

December 11, 1987

NCI Comprehensive Center List Omits Georgetown/Howard, Adds Arizona

June 1, 1990

Oral Contraceptives Related To Liver Tumors; New Studies Urged

March 12, 1976

Reorganization Answer Now Coming In – Viroloy Extramural Research To Be Under Carcinogenesis

March 24, 1978

DCCR Advisors Okay New Programs; $300,000 Year Demonstrations In Six Communities Supported

November 17, 1978

In Congress: Funds Unavailable To Give NIH Big Raise, Appropriators Say

June 5, 1998